Takeda Pharmaceutical Co (TSE:4502) Interest Expense : 円-231,352 Mil (TTM As of Mar. 2024)

Takeda Pharmaceutical Co Interest Expense Chart

Takeda Pharmaceutical Co Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Interest Expense		Get a 7-Day Free Trial					-149,010.00	-130,806.00	-122,432.00	-116,973.00	-219,850.00

Takeda Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															9,792.00	-59,575.00	-58,022.00	-66,568.00	-47,187.00

Takeda Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-231,352 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co  (TSE:4502) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Takeda Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was 円-47,187 Mil. Its Operating Income for the three months ended in Mar. 2024 was 円-10,067 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was 円4,476,501 Mil.

Takeda Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Takeda Pharmaceutical Co Ltds earnings cannot cover its interest expense. If the situation continues, the company may have to issue more debt.

Takeda Pharmaceutical Co (TSE:4502) Business Description